Merck Pulls £1 Billion UK Expansion in Blow to Britain’s Drug Industry
US pharmaceutical giant Merck has scrapped plans for a £1 billion expansion in the UK, blaming weak government support for the life sciences sector. The company, known as MSD in Europe, said it will shift its research focus to the US and cut jobs in Britain. It accused successive UK governments of undervaluing new medicines…